Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Cancer Research|July 5, 2002
Cytokines modulate telomerase activity in a human multiple myeloma cell lineMasaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|April 14, 2005
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.
Blood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.
Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.
Blood|May 27, 2006
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cellsLaurence Catley, Ellen Weisberg, Tanyel Kiziltepe, et al.
The Journal of Biological Chemistry|March 2, 2002
NF-kappa B as a therapeutic target in multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Pageof 17